PTN Palatin Technologies Inc.

1.1
-0.11  -9%
Previous Close 1.21
Open 1.13
Price To Book 15.71
Market Cap 237,111,844
Shares 215,556,222
Volume 14,649,419
Short Ratio 4.11
Av. Daily Volume 3,998,077

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

FDA approval announced June 21, 2019.
Vyleesi (Bremelanotide)
Female sexual dysfunction (FSD)
Phase 2 trial to commence 1H 2019.
PL-3994
Heart failure
Phase 2 trial to commence 4Q 2019.
PL-8177
Non-infectious uveitis
Phase 2 trial to commence 4Q 2019.
PL-8177
Ulcerative colitis

Latest News

  1. Why Palatin Technologies Stock Dropped as Much as 21.5% Today
  2. Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
  3. Palatin's stock rockets after FDA OK to market sexual desire disorder treatment
  4. AMAG stock rallies on FDA approval for drug to increase women's sex drive
  5. FDA Approves New Drug Application for Vyleesi™ (bremelanotide injection)
  6. FDA approves drug for loss of female sexual desire
  7. Edited Transcript of PTN earnings conference call or presentation 9-May-19 3:00pm GMT
  8. What Does Poltronic S.A.'s (WSE:PTN) Balance Sheet Tell Us About It?
  9. Palatin Technologies (PTN) Q3 2019 Earnings Call Transcript
  10. Palatin Technologies, Inc. to Host Earnings Call
  11. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019
  12. Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019
  13. What Kind Of Share Price Volatility Should You Expect For Palatin Technologies, Inc. (NYSEMKT:PTN)?
  14. Palatin Technologies (PTN) in Focus: Stock Moves 5.7% Higher
  15. Palatin Technologies Announces Positive Top Line Results of Oral Clinical Study of PL-8177 for Ulcerative Colitis and Other Inflammatory Bowel Diseases
  16. The Palatin Technologies Share Price Has Gained 103%, So Why Not Pay It Some Attention?
  17. Analysis: Positioning to Benefit within Weatherford International, NiSource, Palatin Technologies, Astronics, MaxLinear, and FutureFuel — Research Highlights Growth, Revenue, and Consolidated Results
  18. Edited Transcript of PTN earnings conference call or presentation 12-Feb-19 4:00pm GMT
  19. Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update
  20. Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019